What are the benefits of targeted drugs?
The targeted drugs had the following benefits: 1. Strong treatment targeting: From the molecular level of cells, drugs are designed to target specific targets on the surface of cancer cells, and more accurately act on the target to control the tumor. They only act on the target and have little effect on normal cell tissues. 2. It has remarkable efficacy: it can effectively kill tumor cells and reduce lumps. In some patients, its efficacy is no less than that of chemotherapy and chemotherapy. It can reduce the symptoms of cancer patients, improve the survival time and quality of life of cancer patients, and make cancer a chronic disease that can be treated continuously to a certain extent, helping patients survive with cancer. 3. Less side effects: Because it has little effect on normal cells and tissues, there are fewer side effects. Compared to treatments such as chemotherapy, there are no side effects of chemotherapy. For example, it will not cause large-scale destruction to normal cells in the body like chemotherapy. Read more exciting novels for free
What are the targeted drugs for immunity drugs?
The immune drugs mainly included nivulumab injection, pabolizuab injection, atilibizab, duvalliumab, carrelizub, etc. The targeted drugs mainly included trastubiza for injection, pertubiza injection, osimertinib, dacotinib, gefitini, erlotinib, icotinib, afartinib, etc.(There were also many targeted drugs for different cancer types, such as osimertinib and dacotinib targeted for the first-line treatment of lung cancer and lung cancer, alectinib, crizotinib, etc. for the first-line treatment of ALK mutation). <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Take the third generation of targeted drugs after the first generation of targeted drugs are resistant
After the first-generation targeted drug became resistant, the third-generation targeted drug could be considered. According to the data in document [2], after the first-generation targeted drug became resistant, only about 25% of patients had the opportunity to use osimertinib for second-line treatment. According to the study mentioned in document [4], the first-line use of osimertinib for the treatment of egfr-positive lung cancer, followed by comprehensive treatment methods such as chemotherapy and chemotherapy after drug resistance, the patient's overall survival time was 41.4 months, which was twice as long as the first-generation targeted drug. In addition, the document [5] mentioned the dual-target combination therapy plan, specifically the first-line treatment of the third-generation TKi osimertinib combined with the first-generation TKi gefitini, with a disease control rate of 100%. Therefore, for patients who were resistant to first-generation targeted drugs, third-generation targeted drugs might be an effective treatment option.
What targeted drugs are there for cd56 positive?
Combociclimax is a targeted plasma cell suppressive agent that can be used to treat multiple marrow tumors. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs for genetic mutation?
There were many types of targeted drugs that were made based on the genetic mutation characteristics of cancer cells. For example, targeted drugs for Kras gene mutation (commonly seen in patients with Colon cancer) include gefitini, regerafenib, sorafenib, bevacizumi, etc.; targeted drugs for the treatment of ERBB2 (also known as HEL2) mutation include trastubiza, pertubiza, lapatini, etc.; For the mutation of Braf15, it is suitable to use a combination of drafenib and trametini. In addition, targeted drugs such as gefitini, icotini, osimetini, bugatini, and other drugs with clear targets (e.g., ADC, ALK, etc.) were also made based on the principle of genetic mutation. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs for serous adenomas?
For high-grade serous adenomas, targeted therapy includes anti-neoplastic targeted drugs such as bevacizumi; for relapsed low-grade serous adenomas, Novartis targeted anti-cancer drug Mekinist (Trametini) has the potential to become a treatment option. In addition, in the treatment of malignant tumors, nirapalide tosylate capsules can be used as a targeted drug for maintenance therapy. For patients who overexpress HEL2/ neu, adding trastubiza (Herceptin) to standard chemotherapy can provide a new solution to improve the prognosis. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs that need to be tested?
In cancer treatment, genetic testing was usually needed to find suitable targets to determine whether targeted drugs could be used. For example, targeted drugs corresponding to mutations in genes such as EGFR, ALK, ROS - 1, BRAF, etc. in lung cancer needed genetic testing to determine the existence of the target before use. In addition, genetic testing was also needed to determine whether cetuxed could be used in the treatment of patients with benign or malignant tumors. However, targeted drugs such as domestic anlotinib, lenvatini, regorafenib, sorafenib, apitini, sunitini, cabotini, cediranil, bevacizumi, and olakumab, as well as bevacizumi in head and neck tumors (such as throat cancer, oral cancer, gum cancer, and other pathological squamous-cell cancer), did not require genetic testing. However, in general, it was more complicated to perform target testing for different tumor diseases and targeted drugs before use. It needed to be analyzed according to the specific situation. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the types of targeted drugs in Henan?
It was known that 17 targeted drugs, including osimertinib, crizotinib, anlotinib, and afartinib, had entered the scope of reimbursement for Henan medical insurance, but it was impossible to determine all types of targeted drugs in Henan based on the available information. However, the common targeted drugs were the first-generation gefitini and erlotini, the second-generation aflatini and dacomitini, and the third-generation osimertinib. Monocentric antibody-type molecular targeted drugs such as trastuzumb (Herceptin), Rituexiu (Mebthera), EMC-C225 (cetoxieb, Erbitux), and Bevacizu (Avastin). Small molecular compounds were commonly used, such as Glivec (ST51, Imatini), Iressa (ZD1839, Gefitini), and OSI774 (Erlotini, Tarcava). <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the 32 targeted drugs for treating cancer?
The following are some cancer-targeted drugs: - The targeted drugs for the first-line treatment of lung adenomas and lung cancer with egfr-mutation included osimertinib, dacotinib, gefitini, erlotinib, icotinib, afartinib, bevacidating, and ramulatumab; the second-line treatment (T790M positive) included osimertinib and amitini; the first-line treatment of ALK mutation included alectinib, crizotinib, ceritini, and bugatini; the second-line treatment of crizotinib-resistant included alectinib, bugatinib, and ceritini; and the second-generation targeted drugs included lorlatini. - There were also palinosetron capsules, metoclopramine tablets, ondansetron capsules, and aprepitant capsules. - Larotinib can be used to treat all advanced solid tumors with NtrK gene fusion, including 21 types of cancer, such as thyreoid cancer, myospasm, primary central nervous system tumor, sialoadenoma, Coloembryonic cancer, leukemia, breast cancer, bone sarcomas, histisarcomas, bile duct cancer, hepatic cancer, congenital mesogenic kidney cancer, primary unknown cancer, apexical cancer, liver cancer, bladder cancer, and cervical cancer. However, the number of targeted drugs explicitly mentioned at present did not reach 32, and the complete information of 32 cancer targeted drugs could not be provided. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the first-generation targeted drugs for adenomas?
The first-generation targeted drugs for lung cancer included gefitini, erlotini, icotini, and conmana. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs for the c797s mutation?
If the C797S mutation appeared only after osimertinib treatment, it could be treated again with first-generation or second-generation targeted drugs such as gefitini. Amivantamab has a certain effect on osimertinib-resistant mutants caused by various EGFR mutations, including the C797S mutation. In addition, the fourth-generation egfr-targeted drug targeting the C797S mutation was still in the clinical research stage. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>